Advances in targeted therapy and biomarker research in thyroid cancer
M Guo, Y Sun, Y Wei, J Xu, C Zhang - Frontiers in Endocrinology, 2024 - frontiersin.org
Driven by the intricacy of the illness and the need for individualized treatments, targeted
therapy and biomarker research in thyroid cancer represent an important frontier in …
therapy and biomarker research in thyroid cancer represent an important frontier in …
MRI-based texture analysis for preoperative prediction of BRAF V600E mutation in papillary thyroid carcinoma
T Zheng, W Hu, H Wang, X Xie, L Tang… - Journal of …, 2023 - Taylor & Francis
Purpose BRAF V600E mutation can compensate for the low detection rate by fine-needle
aspiration (FNA) and is related to aggressiveness and lymph node metastasis. This study …
aspiration (FNA) and is related to aggressiveness and lymph node metastasis. This study …
Ultrasound and clinicopathological characteristics of papillary thyroid carcinoma predict the coexistence of TERT promoter and BRAFV600E mutations
M Yu, ZT Wang, CZ Zhang, SW Lv, W Li, YF Sun, K Liu… - 2023 - researchsquare.com
Purpose: The coexistence of TERT promoter and BRAF V600E mutations is strongly
associated with high aggressiveness and poor prognosis in papillary thyroid carcinoma. The …
associated with high aggressiveness and poor prognosis in papillary thyroid carcinoma. The …